Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage.

Giamarellos-Bourboulis EJ, Pyleris E, Barbatzas C, Pistiki A, Pimentel M.

BMC Gastroenterol. 2016 Jul 11;16(1):67. doi: 10.1186/s12876-016-0484-6.

2.

Reverse kinetics of angiopoietin-2 and endotoxins in acute pyelonephritis: Implications for anti-inflammatory treatment?

Safioleas K, Giamarellos-Bourboulis EJ, Carrer DP, Pistiki A, Sabracos L, Deliveliotis C, Chrisofos M.

Cytokine. 2016 May;81:28-34. doi: 10.1016/j.cyto.2016.01.019. Epub 2016 Feb 5.

PMID:
26844659
3.

In Vitro Activity of Oral Cephalosporins (Cefprozil and Cefixime) Against Ciprofloxacin-Resistant Enterobacteriaceae from Community-Acquired Urinary-Tract Infections.

Pistiki A, Tsaganos T, Galani I, Giamarellos-Bourboulis EJ.

Infect Dis Ther. 2015 Dec;4(4):425-32. doi: 10.1007/s40121-015-0089-3. Epub 2015 Sep 21.

4.

NK and NKT Cell Depletion Alters the Outcome of Experimental Pneumococcal Pneumonia: Relationship with Regulation of Interferon-γ Production.

Christaki E, Diza E, Giamarellos-Bourboulis EJ, Papadopoulou N, Pistiki A, Droggiti DI, Georgitsi M, Machova A, Lambrelli D, Malisiovas N, Nikolaidis P, Opal SM.

J Immunol Res. 2015;2015:532717. doi: 10.1155/2015/532717. Epub 2015 May 31.

5.

Compartmentalized Cytokine Responses in Hidradenitis Suppurativa.

Kanni T, Tzanetakou V, Savva A, Kersten B, Pistiki A, van de Veerdonk FL, Netea MG, van der Meer JW, Giamarellos-Bourboulis EJ.

PLoS One. 2015 Jun 19;10(6):e0130522. doi: 10.1371/journal.pone.0130522. eCollection 2015.

6.

Defective cytokine production early after multiple traumas: Modulation in severe sepsis.

Paraschos MD, Patrani M, Pistiki A, Katsenos C, Tsaganos T, Netea MG, Giamarellos-Bourboulis EJ, Mandragos K.

Cytokine. 2015 Dec;76(2):222-6. doi: 10.1016/j.cyto.2015.05.021. Epub 2015 Jun 13.

PMID:
26082021
7.

Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.

Giamarellos-Bourboulis E, Tang J, Pyleris E, Pistiki A, Barbatzas C, Brown J, Lee CC, Harkins TT, Kim G, Weitsman S, Barlow GM, Funari VA, Pimentel M.

Scand J Gastroenterol. 2015;50(9):1076-87. doi: 10.3109/00365521.2015.1027261. Epub 2015 Apr 11.

PMID:
25865706
8.

Proinflammatory cytokine responses in patients with psoriasis.

Kouris A, Pistiki A, Katoulis A, Georgitsi M, Giatrakou S, Papadavid E, Netea MG, Stavrianeas N, Giamarellos-Bourboulis EJ.

Eur Cytokine Netw. 2014 Oct-Dec;25(4):63-8. doi: 10.1684/ecn.2014.0358.

PMID:
25679113
9.

Pre-treatment with probiotics prolongs survival after experimental infection by multidrug-resistant Pseudomonas aeruginosa in rodents: an effect on sepsis-induced immunosuppression.

Machairas N, Pistiki A, Droggiti DI, Georgitsi M, Pelekanos N, Damoraki G, Kouraklis G, Giamarellos-Bourboulis EJ.

Int J Antimicrob Agents. 2015 Apr;45(4):376-84. doi: 10.1016/j.ijantimicag.2014.11.013. Epub 2015 Jan 6.

PMID:
25601531
10.

Immune responses in relation to the type and time of thermal injury: an experimental study.

Alexis A, Carrer DP, Droggiti DI, Louis K, Pistiki A, Netea MG, Kapessidou Y, Giamarellos-Bourboulis EJ.

Injury. 2015 Feb;46(2):227-32. doi: 10.1016/j.injury.2014.10.057. Epub 2014 Oct 31.

PMID:
25467712
11.

Time-kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin.

Safarika A, Galani I, Pistiki A, Giamarellos-Bourboulis EJ.

Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):317-23. doi: 10.1007/s10096-014-2231-7. Epub 2014 Sep 6.

PMID:
25192733
12.

Immunomodulatory intervention with interferon-γ in Escherichia coli pyelonephritis.

Katsaris MP, Adamis T, Pistiki A, Carrer DP, Galani I, Sabracos L, Droggiti DI, Georgitsi M, Damoraki G, Giamarellos-Bourboulis EJ, Chrisofos M.

J Urol. 2014 Aug;192(2):600-6. doi: 10.1016/j.juro.2014.03.092. Epub 2014 Mar 25.

PMID:
24681329
13.

Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response*.

Katsenos CS, Antonopoulou AN, Apostolidou EN, Ioakeimidou A, Kalpakou GT, Papanikolaou MN, Pistiki AC, Mpalla MC, Paraschos MD, Patrani MA, Pratikaki ME, Retsas TA, Savva AA, Vassiliagkou SD, Lekkou AA, Dimopoulou I, Routsi C, Mandragos KE; Hellenic Sepsis Study Group.

Crit Care Med. 2014 Jul;42(7):1651-7. doi: 10.1097/CCM.0000000000000318.

PMID:
24674923
14.

The immunomodulatory and anti-apoptotic effect of dexamethasone in imminent preterm labor: an experimental study.

Makrydima SF, Pistiki AC, Chrelias CG, Sioulas VD, Siristatidis CS, Giamarellos-Bourboulis EJ, Kassanos DP.

Eur J Pharmacol. 2014 May 5;730:31-5. doi: 10.1016/j.ejphar.2014.02.019. Epub 2014 Feb 26.

PMID:
24582761
15.

Angiopoietin-2 primes infection-induced preterm delivery.

Polyzou EN, Evangelinakis NE, Pistiki A, Kotsaki A, Siristatidis CS, Chrelias CG, Salamalekis E, Kassanos DP, Giamarellos-Bourboulis EJ.

PLoS One. 2014 Jan 21;9(1):e86523. doi: 10.1371/journal.pone.0086523. eCollection 2014.

16.

In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth.

Pistiki A, Galani I, Pyleris E, Barbatzas C, Pimentel M, Giamarellos-Bourboulis EJ.

Int J Antimicrob Agents. 2014 Mar;43(3):236-41. doi: 10.1016/j.ijantimicag.2013.12.008. Epub 2014 Jan 6.

PMID:
24461710
17.

Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect.

Mihailidou I, Pelekanou A, Pistiki A, Spyridaki A, Tzepi IM, Damoraki G, Giamarellos-Bourboulis EJ.

Front Public Health. 2013 Nov 14;1:50. doi: 10.3389/fpubh.2013.00050. eCollection 2013.

18.

Bacterial translocation induces proinflammatory responses and is associated with early death in experimental severe injury.

Baxevanos N, Giamarellos-Bourboulis EJ, Pistiki A, Korre M, Droggiti DI, Tsaganos T.

J Surg Res. 2013 Dec;185(2):844-50. doi: 10.1016/j.jss.2013.07.026. Epub 2013 Aug 2.

PMID:
23953792
19.

Intravenous itraconazole against experimental neutropenic Candida parapsilosis infection: efficacy after suppression of bacterial translocation.

Carrer DP, Samonis G, Droggiti DI, Tsaganos T, Pistiki A, Giamarellos-Bourboulis EJ.

J Infect Chemother. 2013 Dec;19(6):1080-6. doi: 10.1007/s10156-013-0627-4. Epub 2013 Jun 9.

PMID:
23749143
20.

Pre-treatment with low-dose endotoxin prolongs survival from experimental lethal endotoxic shock: Benefit for lethal peritonitis by Escherichia coli.

Kopanakis K, Tzepi IM, Pistiki A, Carrer DP, Netea MG, Georgitsi M, Lymperi M, Droggiti DI, Liakakos T, Machairas A, Giamarellos-Bourboulis EJ.

Cytokine. 2013 Jun;62(3):382-8. doi: 10.1016/j.cyto.2013.03.028. Epub 2013 Apr 19.

PMID:
23602853
Items per page

Supplemental Content

Loading ...
Write to the Help Desk